Pritchard, K., Gelmon, K., Rayson, D., Provencher, L., Webster, M., McLeod, D., & Verma, S. (2013). Endocrine therapy for postmenopausal women with hormone receptor–positive her2–negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: A Canadian consensus statement. Multimed Inc.

Pritchard, K.I., K.A Gelmon, D. Rayson, L. Provencher, M. Webster, D. McLeod, e S. Verma. Endocrine Therapy for Postmenopausal Women With Hormone Receptor–positive Her2–negative Advanced Breast Cancer After Progression or Recurrence On Nonsteroidal Aromatase Inhibitor Therapy: A Canadian Consensus Statement. Multimed Inc, 2013.

Pritchard, K.I., et al. Endocrine Therapy for Postmenopausal Women With Hormone Receptor–positive Her2–negative Advanced Breast Cancer After Progression or Recurrence On Nonsteroidal Aromatase Inhibitor Therapy: A Canadian Consensus Statement. Multimed Inc, 2013.